(Q37878473)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21604945%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

review article

1 reference

title

Tumour markers in prostate cancer III: biomarkers in urine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21604945%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21604945%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Alexander Haese

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21604945%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Anders Bjartell

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21604945%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

1 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21604945%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21604945%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

50 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21604945%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

85-89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21604945%20AND%20SRC:MED&resulttype=core&format=json

Screening and prostate-cancer mortality in a randomized European study

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

Annexin A3 in urine: a highly specific noninvasive marker for prostate cancer early detection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

New functions for the matrix metalloproteinases in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

Urine biomarkers in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

Identification of extracellular delta-catenin accumulation for prostate cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

Urine analysis and protein networking identify met as a marker of metastatic prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

Development of a sensitive and specific enzyme-linked immunosorbent assay for thymosin beta15, a urinary biomarker of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

Quantitative GSTP1 Methylation and the Detection of Prostate Adenocarcinoma in Sextant Biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

Development of a multiplexed urine assay for prostate cancer diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

DNA methylation biomarkers of prostate cancer: confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

Multicenter evaluation of an investigational prostate cancer methylation assay

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

Urinary prostate cancer 3 test: toward the age of reason?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

DD3PCA3 RNA analysis in urine--a new perspective for detecting prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

uPM3, a new molecular urine test for the detection of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

PCA3: a molecular urine assay for predicting prostate biopsy outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

Evaluation of the ETS-related gene mRNA in urine for the detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935

The role of SPINK1 in ETS rearrangement-negative prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.524935